Interestingly, we found that bioactive GA decreased the protein and mRNA levels of PD-L1 as compared with the control experiment, and the expression levels of p53 and miR-34a were upregulated by GA in NSCLC cells. The gene discussed is TP53; the disease is non-small cell lung carcinoma.